Cargando…
Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons
Amita Gupta and colleagues discuss priorities in clinical research aimed at improving tuberculosis prevention and treatment in pregnant women, children, and people with HIV.
Autores principales: | Gupta, Amita, Hughes, Michael D., Garcia-Prats, Anthony J., McIntire, Katherine, Hesseling, Anneke C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695091/ https://www.ncbi.nlm.nih.gov/pubmed/31415563 http://dx.doi.org/10.1371/journal.pmed.1002882 |
Ejemplares similares
-
Extending lactation length: consequences for cow, calf, and farmer
por: van Knegsel, Ariette T M, et al.
Publicado: (2022) -
Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis
por: van der Laan, Louvina E., et al.
Publicado: (2021) -
Gender-Related Barriers and Delays in Accessing Tuberculosis Diagnostic and Treatment Services: A Systematic Review of Qualitative Studies
por: Krishnan, Lakshmi, et al.
Publicado: (2014) -
Preovulatory serum estradiol concentration is positively associated with oocyte ATP and follicular fluid metabolite abundance in lactating beef cattle
por: Read, Casey C, et al.
Publicado: (2022) -
Barriers to Initiation of Antiretrovirals during Antituberculosis
Therapy in Africa
por: Pepper, Dominique J., et al.
Publicado: (2011)